- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01010919
A Study of Chicory for Treatment of Osteoarthritis of the Hip or Knee
November 9, 2009 updated by: Phytomedics Inc.
A Phase I Study of Chicory for Treatment of Osteoarthritis of the Hip or Knee
Extracts of chicory root have anti-inflammatory properties in vitro and in animal models of arthritis.
The primary objective of this investigator-initiated, Phase 1, placebo-controlled, double blind, dose-escalating trial is to determine the safety and tolerability of a proprietary bioactive extract of chicory root in patients with osteoarthritis (OA).
Secondary objectives are to assess effects on the signs and symptoms of this disorder.
Individuals greater than 50 years of age with OA of the hip or knee will be eligible for trial entry.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
48 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients must be 50 years of age or older and may be of either gender.
- Patients must have have an imaging-confirmed (radiograph or MRI) diagnosis of OA of the hip or knee.
- Patients must not have taken a nonsteroidal anti-inflammatory medication for at least 7 days prior to the baseline visit (a single daily aspirin 325 mg or less is allowed throughout the study).
- Patients must be able and willing to give informed consent.
Exclusion Criteria:
- Any unstable comorbid medical condition that in the opinion of the investigator could interfere with the ability of the patient to complete the study.
- Patients who are unable to ambulate and require a wheelchair due to the severity of the arthritis are excluded. Ambulatory aids such as canes and walkers are acceptable.
- Patients requiring continuing therapy with nonsteroidal anti-inflammatory drugs are excluded.
- Patients requiring any dose of glucocorticoids within the past 30 days are excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
November 6, 2009
First Submitted That Met QC Criteria
November 9, 2009
First Posted (Estimate)
November 10, 2009
Study Record Updates
Last Update Posted (Estimate)
November 10, 2009
Last Update Submitted That Met QC Criteria
November 9, 2009
Last Verified
November 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PMI-005-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis
-
Sanford HealthActive, not recruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder Osteoarthritis | Ankle Osteoarthritis | Wrist OsteoarthritisUnited States
-
University of EdinburghHospital for Special Surgery, New YorkRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited Kingdom
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
University of California, San FranciscoStanford University; Robert Wood Johnson FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
University of VermontCompletedOsteoarthritis of Knee | Osteoarthritis Of HipUnited States
-
Hospital for Special Surgery, New YorkRoyal Infirmary of EdinburghRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited States, United Kingdom
-
Ottawa Hospital Research InstituteNot yet recruitingKnee Osteoarthritis | Hip Osteoarthritis
-
University Hospital, LilleCompleted
-
Massachusetts General HospitalNewton-Wellesley Hospital; The New England Baptist HospitalCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
Clinical Trials on Chicory root extract
-
University Medical Center GroningenMyMicroZoo; WholeFiberNot yet recruiting
-
Wageningen UniversityWholeFiber BVNot yet recruitingBowel Function DissatisfactionNetherlands
-
Dr. Willmar Schwabe GmbH & Co. KGCompletedCommon ColdUnited Kingdom
-
Jeeyoun MoonNot yet recruitingFacet Joint Syndrome
-
Abbott NutritionCompletedType 2 DiabetesUnited States
-
University of WashingtonNational Center for Complementary and Integrative Health (NCCIH)CompletedSleep Initiation and Maintenance DisordersUnited States
-
SF Research Institute, Inc.Recruiting
-
Tanta UniversityActive, not recruitingChronic PeriodontitisEgypt
-
Blanca Roman-Viñas, MDActive, not recruiting
-
HaEmek Medical Center, IsraelUnknownDiabetes Mellitus | AtherosclerosisIsrael